Education
About Us
Working with TipRanks
Follow Us
Cryo-Cell International (CCEL)
:CCEL
CCEL Stock Chart & Stats
$4.54
-$0.37(-4.74%)
At close: 4:00 PM EST
$4.54
-$0.37(-4.74%)
Day’s Range― - ―
52-Week Range$4.09 - $9.43
Previous CloseN/A
Volume3.40K
Average Volume (3M)20.83K
Market Cap
$35.80M
Enterprise Value$52.94M
Total Cash (Recent Filing)$4.43M
Total Debt (Recent Filing)$9.15M
Price to Earnings (P/E)380.0
Beta0.04
Next Earnings
Feb 26, 2026EPS EstimateN/A
Last Dividend Ex-Date
May 21, 2025Dividend Yield8.81%
Share Statistics
EPS (TTM)0.09
Shares Outstanding8,062,159
10 Day Avg. Volume7,519
30 Day Avg. Volume20,833
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.48
Enterprise Value/Revenue1.65
Enterprise Value/Gross Profit2.17
Enterprise Value/Ebitda14.62
Forecast
1Y Price Target
$8.50Price Target Upside87.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Business ModelCryo-Cell's core business of processing and storing stem cells has high margins and mostly recurring revenue.
Financial PerformanceCryo-Cell International, Inc. reported a strong EBITDA performance in the second quarter.
Bears Say
Legal IssuesThe company is involved in arbitration against Duke University, which could lead to higher legal expenses and potential financial implications.
Revenue ProjectionsThe full-year 2025 revenue projections have been lowered.
Cryo-Cell International News
CCEL FAQ
What was Cryo-Cell International’s price range in the past 12 months?
Cryo-Cell International lowest stock price was $4.09 and its highest was $9.43 in the past 12 months.
What is Cryo-Cell International’s market cap?
Cryo-Cell International’s market cap is $35.80M.
When is Cryo-Cell International’s upcoming earnings report date?
Cryo-Cell International’s upcoming earnings report date is Feb 26, 2026 which is in 133 days.
How were Cryo-Cell International’s earnings last quarter?
Cryo-Cell International released its earnings results on Oct 15, 2025. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of -$0.03 by $0.12.
Is Cryo-Cell International overvalued?
According to Wall Street analysts Cryo-Cell International’s price is currently Undervalued.
Does Cryo-Cell International pay dividends?
Cryo-Cell International pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 8.81%. See more information on Cryo-Cell International dividends here
What is Cryo-Cell International’s EPS estimate?
Cryo-Cell International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryo-Cell International have?
Cryo-Cell International has 8,062,159 shares outstanding.
What happened to Cryo-Cell International’s price movement after its last earnings report?
Cryo-Cell International reported an EPS of $0.09 in its last earnings report, beating expectations of -$0.03. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cryo-Cell International?
Currently, no hedge funds are holding shares in CCEL
Cryo-Cell International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (87.22% Upside)
$8.50 (87.22% Upside)
Insider Transactions
Bought Shares
Worth $552.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.85%
12-Months-Change
Fundamentals
Return on Equity
93.38%
Trailing 12-Months
Asset Growth
2.99%
Trailing 12-Months
Company Description
Cryo-Cell International
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
CCEL Stock 12 Month Forecast
Average Price Target
$8.50
▲(87.22% Upside)
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
ModivCare
―
DocGo
―
P3 Health Partners
―
Ownership Overview
33.18% Insiders
2.09% Mutual Funds
7.64% Other Institutional Investors
55.36% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---